Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents
23 Jun, 2017 | 21:10h | UTCEverolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Metallic Stents – Journal of the American College of Cardiology (free) (RT @JACCJournals see Tweet)
In this meta-analysis including 7 randomized trials bioresorbable vascular scaffolds were associated with both lower efficacy and higher thrombotic risk over time.